Cargando…
Liraglutide-Induced Hemorrhagic Pancreatitis in a Nondiabetic Patient
Liraglutide is a glucagon-like peptide 1 (GLP-1) analog with a primary effect of increased glucose-dependent insulin secretion and decreased gastric emptying. It serves as a feasible medical weight loss option because of the drug's effect of invoking satiety and lowering caloric intake. Despite...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289281/ https://www.ncbi.nlm.nih.gov/pubmed/32607380 http://dx.doi.org/10.14309/crj.0000000000000380 |